COST-EFFECTIVENESS OF TREATING ACUTE CORONARY SYNDROME PATIENTS WITH RIVAROXBAN IN AUSTRALIA

被引：0
|
作者：
Gao, L. [1 ]
Li, S. C. [1 ]
机构：
[1] Univ Newcastle, Callaghan, NSW 2308, Australia
来源：
VALUE IN HEALTH | 2014年 / 17卷 / 07期
关键词：
D O I：
10.1016/j.jval.2014.08.255
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PCV30
引用
收藏
页码：A760 / A760
页数：1
相关论文
共 50 条
  • [21] Cost-effectiveness analysis of ticagrelor compared to clopidogrel for the treatment of patients with acute coronary syndrome in Colombia
    Mejia, Aurelio
    Manuel, Juan, Sr.
    Ceballos, Mateo
    Atehortua, Sara
    Manuel Toro, Juan
    Saldarriaga, Clara
    Elena Mejia, Maria
    Ramirez, Carolina
    BIOMEDICA, 2015, 35 (04): : 531 - 540
  • [22] ANALYSIS OF COST-EFFECTIVENESS AND COST-BENEFIT OF THE RIVAROXABAN ADDITION IN THE TREATMENT OF PATIENTS WITH ACUTE CORONARY SYNDROME IN COLOMBIA
    Romero, M.
    Marrugo, R.
    Paez, M. L.
    VALUE IN HEALTH, 2015, 18 (07) : A830 - A830
  • [23] The cost-effectiveness of treating patients with restless legs syndrome (RLS) using ropinirole
    Moore, A. P.
    Lloyd, A.
    Scott, D.
    Connolly, M. P.
    Dixon, S.
    EUROPEAN JOURNAL OF NEUROLOGY, 2004, 11 : 116 - 116
  • [24] The cost-effectiveness of treating patients with restless legs syndrome (RLS) using ropinirole
    Moore, AP
    Lloyd, A
    Scott, DA
    Connolly, M
    Dixon, S
    VALUE IN HEALTH, 2004, 7 (06) : 791 - 791
  • [25] Cost-effectiveness of ticagrelor in acute coronary syndromes
    Henriksson, Martin
    Janzon, Magnus
    EXPERT REVIEW OF PHARMACOECONOMICS & OUTCOMES RESEARCH, 2013, 13 (01) : 9 - 18
  • [26] Cost-effectiveness of coronary MDCT in the triage of patients with acute chest pain
    Ladapo, Joseph A.
    Hoffmann, Udo
    Bamberg, Fabian
    Nagurney, John T.
    Cutler, David M.
    Weinstein, Milton C.
    Gazelle, G. Scott
    AMERICAN JOURNAL OF ROENTGENOLOGY, 2008, 191 (02) : 455 - 463
  • [27] THE COST-EFFECTIVENESS OF RIVAROXABAN FOR THE PREVENTION OF CARDIOVASCULAR (CV) EVENTS IN PATIENTS WITH ACUTE CORONARY SYNDROME (ACS) IN TURKEY
    Parali, E.
    Deger, C.
    Ozdemir, O.
    Afsar, N.
    Aykut Aka, S.
    Degertekin, M.
    Ergene, O.
    Ongen, Z.
    Ozdemir, M.
    Sumer, F.
    Yilmaz, Z. S.
    Ozel, M. O.
    VALUE IN HEALTH, 2014, 17 (03) : A115 - A115
  • [28] COST-EFFECTIVENESS OF UNIVERSAL VERSUS ASSAY-DRIVEN ANTIPLATELET THERAPY IN ACUTE CORONARY SYNDROME PATIENTS
    Coleman, C., I
    Limone, B. L.
    VALUE IN HEALTH, 2013, 16 (03) : A284 - A284
  • [29] Cost-Effectiveness of Exercise-Based Cardiac Rehabilitation in Chilean Patients Surviving Acute Coronary Syndrome
    Seron, Pamela
    Gaete, Monica
    Oliveros, Maria-Jose
    Roman, Claudia
    Lanas, Fernando
    Velasquez, Monica
    Reveco, Roberto
    Bustos, Luis
    Rojas, Ruben
    JOURNAL OF CARDIOPULMONARY REHABILITATION AND PREVENTION, 2019, 39 (03) : 168 - 174
  • [30] Analysis of the cost-effectiveness of clopidogrel in patients with acute coronary syndrome (vol 58, pg 1385, 2005)
    Badia, X
    REVISTA ESPANOLA DE CARDIOLOGIA, 2006, 59 (02): : 185 - 185
12345